Showing results (1071-1080 of 1,390) with videos related to
Sort By:
Pageof 139
Radiology. Cardiothoracic Imaging|March 29, 2021
Variability of MRI Aortic Stiffness Measurements in a Multicenter Clinical Trial Setting: Intraobserver, Interobserver, and Intracenter Variability of Pulse Wave Velocity and Aortic Strain MeasurementMaja Hrabak-Paar, Achim Kircher, Saeed Al Sayari, et al.Proceedings of the National Academy of Sciences of the United States of America|April 17, 2023
TapA acts as specific chaperone in TasA filament formation by strand complementationYvette Roske, Florian Lindemann, Anne Diehl, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 3, 2020
Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trialKazuomi Kario, Michael A Weber, Michael Böhm, et al.Chemical Science|April 3, 2023
Real-time monitoring of the sialic acid biosynthesis pathway by NMRJacob L Gorenflos López, Peter Schmieder, Kristin Kemnitz-Hassanin, et al.Journal of Hypertension|December 18, 2025
Impact of centrally acting sympatholytic agents on the blood pressure response to renal denervationJanis M Nolde, Márcio Galindo Kiuchi, Revathy Carnagarin, et al.American Heart Journal|May 30, 2021
Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medicationsFelix Mahfoud, Michael Weber, Roland E Schmieder, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 27, 2024
36-month durability of ultrasound renal denervation for hypertension resistant to combination therapy in RADIANCE-HTN TRIOMichael J Bloch, Ajay J Kirtane, Michel Azizi, et al.Circulation|September 28, 2011
Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)Giuseppe Mancia, Helmut Schumacher, Josep Redon, et al.American Journal of Respiratory Cell and Molecular Biology|October 8, 2011
Case studies of the spatial heterogeneity of DNA viruses in the cystic fibrosis lungDana Willner, Matthew R Haynes, Mike Furlan, et al.Journal of Hypertension|September 5, 2020
Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trialsGiuseppe Mancia, Helmut Schumacher, Michael Böhm, et al.Pageof 139